Delaye M - Search Results

1

Patients' knowledge about renal secondary effects of anti-tumoral drugs and renal protection measures.

Corbaux P, Bainaud M, Rousseau A, Try M, Saillant A, Lafargue MC, Stocker N, Afchain P, Jamelot M, Isnard-Bagnis C, Campedel L, Delaye M. Corbaux P, et al. Among authors: delaye m. Support Care Cancer. 2024 Nov 1;32(11):763. doi: 10.1007/s00520-024-08956-8. Support Care Cancer. 2024. PMID: 39482406

2

Onco-nephrology: Physicians' Expectations About a New Subspecialty.

Delaye M, Try M, Rousseau A, Lafargue MC, Saillant A, Bainaud M, Andreani M, Rozenblat D, Campedel L, Corbaux P, Isnard-Bagnis C. Delaye M, et al. J Cancer Educ. 2023 Jun;38(3):878-884. doi: 10.1007/s13187-022-02201-8. Epub 2022 Jul 15. J Cancer Educ. 2023. PMID: 35840858

3

Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer.

Delaye M, Rousseau A, Try M, Massard C, Campedel L, Hilmi M, Bagnis C. Delaye M, et al. Cancer Med. 2023 Feb;12(3):3172-3175. doi: 10.1002/cam4.5171. Epub 2022 Sep 26. Cancer Med. 2023. PMID: 36156460 Free PMC article. Clinical Trial.

4

[Onco-nephrology: Origins, organization and perspectives].

Delaye M, Bay JO, Thiery-Vuillemin A, Isnard-Bagnis C. Delaye M, et al. Bull Cancer. 2024 Jul-Aug;111(7-8):661-662. doi: 10.1016/j.bulcan.2022.06.008. Bull Cancer. 2024. PMID: 38950934 French. No abstract available.

5

[Kidney function and cancer treatment: which problems for the oncologist?].

Delaye M, Zahr N, Isnard-Bagnis C, Gougis P, Campedel L. Delaye M, et al. Rev Prat. 2021 Feb;71(2):206-211. Rev Prat. 2021. PMID: 34160985 French. No abstract available.

6

Discussion on methadone initiation protocols: A case report.

Delaye M, Laurent S, Try M, Treillet E. Delaye M, et al. J Opioid Manag. 2022 Sep-Oct;18(5):487-491. doi: 10.5055/jom.2022.0742. J Opioid Manag. 2022. PMID: 36226788

7

Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?

Delaye M, Rousseau A, Mailly-Giacchetti L, Assoun S, Sokol H, Neuzillet C. Delaye M, et al. Pharmacol Ther. 2023 Jul;247:108442. doi: 10.1016/j.pharmthera.2023.108442. Epub 2023 May 18. Pharmacol Ther. 2023. PMID: 37210004 Review.

8

[Last year of residency for oncologists: Overview and perspectives].

Laune Q, Varnier R, Rousseau A, Larnaudie A, Ghannam Y, Huguet F, Delaye M. Laune Q, et al. Among authors: delaye m. Bull Cancer. 2024 Feb;111(2):142-152. doi: 10.1016/j.bulcan.2023.08.005. Epub 2023 Oct 14. Bull Cancer. 2024. PMID: 37845094 French.

9

[Goals, motivations, and difficulties of young oncology residents].

Hilmi M, Ashton E, Delaye M, Giraud P, Neuzillet C, Spano JP, Gligorov J, Ollivier L, Rousseau A, Naoun N, Boilève A. Hilmi M, et al. Among authors: delaye m. Bull Cancer. 2022 Feb;109(2):119-129. doi: 10.1016/j.bulcan.2021.09.020. Epub 2021 Nov 19. Bull Cancer. 2022. PMID: 34809979 French.

10

Perspectives of oncology residents on Master's Degree in Science (MSc) programs: a national descriptive study by the French Association of Residents in Oncology (AERIO).

Matte P, Rousseau A, Courtier B, Duval M, Laune Q, Duval J, Kfoury M, Delaye M. Matte P, et al. Among authors: delaye m. ESMO Open. 2024 May;9(5):103445. doi: 10.1016/j.esmoop.2024.103445. Epub 2024 Apr 25. ESMO Open. 2024. PMID: 38669772 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters